These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8791186)
1. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion. Curtin F; Walker JP; Schulz P J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186 [TBL] [Abstract][Full Text] [Related]
2. Reliability of urinary monoamine and metabolite output measurements in depressed patients. Linnoila M; Karoum F; Miller T; Potter WZ Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580 [TBL] [Abstract][Full Text] [Related]
3. Methylated catecholamine metabolites for diagnosis of neuroblastoma. Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031 [TBL] [Abstract][Full Text] [Related]
4. High correlations of norepinephrine, dopamine, and epinephrine and their major metabolite excretion rates. Linnoila M; Oliver J; Adinoff B; Potter WZ Arch Gen Psychiatry; 1988 Aug; 45(8):701-4. PubMed ID: 3395200 [TBL] [Abstract][Full Text] [Related]
5. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication. Zametkin AJ; Hamburger SD Biol Psychiatry; 1988 Feb; 23(4):350-6. PubMed ID: 3342265 [TBL] [Abstract][Full Text] [Related]
6. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans. Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832 [TBL] [Abstract][Full Text] [Related]
7. Biogenic amine/metabolite response during in-flight emergencies. Krahenbuhl GS; Harris J; Malchow RD; Stern JR Aviat Space Environ Med; 1985 Jun; 56(6):576-80. PubMed ID: 2409957 [TBL] [Abstract][Full Text] [Related]
8. Catecholamine metabolism during heroin use. Schildkraut JJ; Meyer RE; Orsulak PJ; Mirin SM; Roffman M; Platz PA; Grab E; Randall ME; McDougle M Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581 [TBL] [Abstract][Full Text] [Related]
9. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878 [TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of monoamines and metabolites in patients dependent on and withdrawn from barbiturates. Turnbull MJ; Ballinger BR Psychopharmacologia; 1973 May; 30(2):103-8. PubMed ID: 4711367 [No Abstract] [Full Text] [Related]
11. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. Davis JM; Koslow SH; Gibbons RD; Maas JW; Bowden CL; Casper R; Hanin I; Javaid JI; Chang SS; Stokes PE Arch Gen Psychiatry; 1988 Aug; 45(8):705-17. PubMed ID: 2456047 [TBL] [Abstract][Full Text] [Related]
12. [Routine gas chromatographic analysis of metanephrine/normetanephrine, 3-methoxy-4-hydroxyphenylglycol and vanilmandelic acid in urine as TMS-vanillin or -vanillyl alcohol]. Schwedt G; Blödorn A; Bussemas HH Clin Chim Acta; 1975 Dec; 65(3):309-18. PubMed ID: 1204221 [No Abstract] [Full Text] [Related]
13. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine. Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615 [TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations. Siirtola T; Sonninen V; Rinne UK Clin Neurol Neurosurg; 1975; 78(2):77-88. PubMed ID: 1222507 [TBL] [Abstract][Full Text] [Related]
16. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Schildkraut JJ; Orsulak PJ; LaBrie RA; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA Arch Gen Psychiatry; 1978 Dec; 35(12):1436-9. PubMed ID: 727879 [TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of catecholamines and their metabolites in relation to circulating catecholamines. Six-hour infusion of epinephrine and norepinephrine in healthy volunteers. Moleman P; Tulen JH; Blankestijn PJ; Man in 't Veld AJ; Boomsma F Arch Gen Psychiatry; 1992 Jul; 49(7):568-72. PubMed ID: 1627048 [TBL] [Abstract][Full Text] [Related]
18. Catecholamine measures for diagnosis and treatment of patients with depressive disorders. Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524 [TBL] [Abstract][Full Text] [Related]
19. Quantification of urinary catecholamines, their abundant metabolites, and 5-hydroxyindoleacetic acid by high performance liquid chromatography and electrochemical detection, using a single mobile phase and uniform isocratic conditions. Radjaipour M; Raster H; Liebich HM Eur J Clin Chem Clin Biochem; 1994 Aug; 32(8):609-13. PubMed ID: 7529572 [TBL] [Abstract][Full Text] [Related]
20. Urinary monoamines and monoamine metabolites in subtypes of unipolar depressive disorder and normal controls. Roy A; Pickar D; Douillet P; Karoum F; Linnoila M Psychol Med; 1986 Aug; 16(3):541-6. PubMed ID: 3763772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]